Key result
Prenatal NSAID therapy in a fetus with severe tricuspid valve dysplasia and circular shunt promoted ductal constriction, achieving near-term delivery and conservative neonatal management.
Why the study?
Tricuspid valve dysplasia is a rare congenital heart defect that can lead to life-threatening fetal circulation compromise.
Does prenatal NSAID therapy improve fetal survival and prolong pregnancy in a fetus with severe tricuspid dysplasia and a circular shunt?
Case Report (n=1)
Does prenatal NSAID therapy improve fetal survival and prolong pregnancy in a fetus with severe tricuspid dysplasia and a circular shunt?
Prenatal NSAID therapy may be a viable novel approach to promote ductal constriction and prolong pregnancy in fetuses with severe tricuspid dysplasia and a circular shunt.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for prenatal NSAIDs in fetal tricuspid dysplasia with circular shunt; prospective trials needed before clinical adoption.
Tricuspid valve dysplasia (TVD) is a rare congenital heart defect that can lead to a life-threatening fetal circulation compromise. We report a case of a fetus with TVD diagnosed at 22 weeks gestation, characterized by severe tricuspid regurgitation, retrograde flow through the ductus arteriosus, and pulmonary regurgitation (circular shunt). Prenatal management with nonsteroidal anti-inflammatory drugs (NSAIDs), both ibuprofen (400–600 mg, every 8 h) and indomethacin (50 mg, every 8 h), was initiated at 28 weeks gestation, and continued until birth, to promote ductal constriction and antegrade flow through it, thus terminating or reducing the circular shunt. Despite the challenging management with NSAIDs, it was possible to achieve a near term delivery and conservative neonatal management. This case highlights the potential of NSAIDs as a therapeutic option in managing severe TVD with a circular shunt, improving fetal survival and prolonging pregnancy for better neonatal outcomes.
No takes yet. Share an insight, caveat, or question.
Rito et al. (2025) conducted a case report in Tricuspid valve dysplasia with circular shunt (n=1). NSAIDs (ibuprofen and indomethacin) was evaluated on Near term delivery and conservative neonatal management. Prenatal NSAID therapy in a fetus with severe tricuspid valve dysplasia and circular shunt promoted ductal constriction, achieving near-term delivery and conservative neonatal management.
Synapse has enriched 10 related papers. Consider them for comparative context: